Marcel Simon Award
Awarded every two years for excellence in the research of genetic hemochromatosis
Marcel Simon was Head of the Diabetology Unit and Dean of the Faculty of Medicine at Rennes University, France. Very proud of his Briton roots and endowed with a marked sense of humour, he got interested very early in hemochromatosis, as his MD thesis was entitled “Heredity of Idiopathic Hemochromatosis.” He soon became a pioneer in the genetics of hemochromatosis, in 1975 by showing the close linkage of the disease to the HLA system on chromosome 6, and in 1977 by demonstrating its recessive mode of inheritance. This opened the way to efficient family screenings. His premature death in 1988, aged 53, was a great loss for the Iron Field. It is to pay tribute to his major contributions and attractive personality that the Marcel Simon Prize was created, and is awarded for excellence in the research of genetic hemochromatosis, at the IBIS meeting every two years.
The Marcel Simon Award is funded by “The Margrit Krikker, M.D. Endowment Fund.”
2023
Caroline Enns, PhD
2019
Paul Adams, MD
(for contributions to the understanding of hereditary hemochromatosis prevalence, its diagnosis and treatment)
2019
Stefano Rivella, PhD
(for contributions to the understanding of dyserythropoiesis in thalassemia)
2017
Chaim Herschko, MD
(for the role of NTBI in systemic iron overload)
2017
John B. Porter, MA, MD, FRCP DRCPath
(for the role of NTBI in systemic iron overload)
2015
Ioav Cabantchik, MD, PhD
(for the role of labile iron in health and disease)
2013
Pierre Brissot, MD
(for Lifetime Achievement)
2011
Jerry Kaplan, PhD
(for Lifetime Achievement)
2009
Jodie Babitt, MD
(for research regarding the role of BMP-6 in Iron Homeostasis)
2009
Marie-Paule Roth, MD
(for research regarding the role of BMP-6 in Iron Homeostasis)
2007
Nancy Andrews, MP, PhD
(for animal models of hemochromatosis)
2005
Sophie Vaulont, MD, PhD
(for the discovery of hepcidin)
2005
Tomas Ganz, MD, PhD
(for the discovery of hepcidin)
2005
Oliver Loreal, MD, PhD
(for the discovery of hepcidin)
2003
Clara Camaschella, MD
(for the study of non-HFE hemochromatosis)
2001
Robert E. Fleming, MD
(for the study of HFE biology)
1999
Jose A. Lebron, PhD
(for the characterization of HFE structure and interactions)
1997
John N. Feder, PhD
(for the identification of HFE)
1995
Antonello Pietrangelo, MD
(for the studies on the pathogenesis of hemochromatosis)
1993
Wolfgang Stremmel, MD
(for the studies on protein for intestinal iron-uptake)
1991
Lawrie Powell, MD, PhD
(for the studies on clinical aspects of Hemochromatosis)
1991
June Halliday, PhD
(for the studies on clinical aspects of Hemochromatosis)
1989
Bruce R. Bacon, MD
(for the studies on Iron toxicity)